Total Payments
$156,635
2024 Payments
$16,138
Companies
19
Transactions
119
Medicare Patients
953
Medicare Billing
$174,912
Payment Breakdown by Category
Consulting$138,130 (88.2%)
Travel$11,630 (7.4%)
Food & Beverage$4,680 (3.0%)
Research$1,600 (1.0%)
Other$540.00 (0.3%)
Gifts$55.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $138,130 | 35 | 88.2% |
| Travel and Lodging | $11,630 | 41 | 7.4% |
| Food and Beverage | $4,680 | 39 | 3.0% |
| Unspecified | $1,600 | 1 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 1 | 0.3% |
| Entertainment | $90.00 | 1 | 0.1% |
| Gift | $55.00 | 1 | 0.0% |
Payments by Type
General
$155,035
118 transactions
Research
$1,600
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $30,467 | 19 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $27,500 | 7 | $0 (2024) |
| Celgene Corporation | $25,512 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $13,999 | 10 | $0 (2018) |
| National Marrow Donor Program | $12,531 | 44 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $10,094 | 5 | $0 (2024) |
| Partner Therapeutics, Inc. | $6,875 | 2 | $0 (2020) |
| Astellas Pharma Global Development | $6,820 | 3 | $0 (2024) |
| AbbVie, Inc. | $5,764 | 8 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $4,575 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,138 | 26 | National Marrow Donor Program ($5,020) |
| 2023 | $22,111 | 19 | E.R. Squibb & Sons, L.L.C. ($12,000) |
| 2022 | $15,945 | 17 | E.R. Squibb & Sons, L.L.C. ($11,000) |
| 2021 | $18,540 | 4 | JAZZ PHARMACEUTICALS INC. ($7,040) |
| 2020 | $24,450 | 7 | Celgene Corporation ($13,000) |
| 2019 | $22,347 | 14 | Gilead Sciences, Inc. ($15,817) |
| 2018 | $16,333 | 14 | Merck Sharp & Dohme Corporation ($6,650) |
| 2017 | $20,770 | 18 | Gilead Sciences Inc ($7,981) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | National Marrow Donor Program | — | Gift | In-kind items and services | $55.00 | General |
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $143.43 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/20/2024 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $2,935.00 | General |
| 11/01/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $494.72 | General |
| 11/01/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $199.48 | General |
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 09/30/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 09/20/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $410.00 | General |
| 09/20/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 08/07/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.56 | General |
| 06/14/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $204.25 | General |
| 06/07/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $205.00 | General |
| 06/07/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $158.00 | General |
| 06/06/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $562.91 | General |
| 06/06/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $209.00 | General |
| 04/28/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.51 | General |
| 04/18/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $109.89 | General |
| Category: Hematology/Oncology | ||||||
| 02/21/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $129.86 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/02/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $266.00 | General |
| 01/19/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $1,156.00 | General |
| 01/19/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $481.00 | General |
| 01/18/2024 | National Marrow Donor Program | — | Entertainment | In-kind items and services | $90.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A TWO-PART, MULTI-CENTER, PROSPECTIVE, PHASE 23 CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF GLASSIA AS AN ADD-ON BIOPHARMACOTHERAPY TO CONVENTIONAL STEROID TREATMENT IN SUBJECTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE WITH LOWER GASTROINTESTINAL INVOLVEMENT | Shire North American Group Inc | $1,600 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 249 | 576 | $234,325 | $48,116 |
| 2022 | 5 | 234 | 527 | $241,880 | $46,773 |
| 2021 | 6 | 242 | 500 | $204,420 | $45,649 |
| 2020 | 6 | 228 | 467 | $147,959 | $34,374 |
Total Patients
953
Total Services
2,070
Medicare Billing
$174,912
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 107 | 238 | $97,589 | $19,281 | 19.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 176 | $48,928 | $11,887 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 80 | $57,968 | $9,805 | 16.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 40 | $15,960 | $4,063 | 25.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 17 | $6,885 | $1,675 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 25 | $6,995 | $1,405 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 73 | 137 | $97,680 | $16,948 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 97 | 203 | $81,257 | $16,225 | 20.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 92 | $36,708 | $8,079 | 22.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 69 | $19,182 | $4,214 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 26 | $7,053 | $1,307 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 113 | 236 | $80,564 | $19,180 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 69 | 133 | $80,505 | $16,771 | 20.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 51 | $20,349 | $4,572 | 22.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 47 | $13,066 | $2,931 | 22.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 12 | $4,860 | $1,119 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 21 | $5,076 | $1,077 | 21.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 96 | 186 | $50,566 | $11,922 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 90 | $33,726 | $8,253 | 24.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 50 | 68 | $34,702 | $6,623 | 19.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 71 | $18,766 | $4,519 | 24.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 20 | 32 | $6,438 | $2,148 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 20 | $3,761 | $908.25 | 24.1% |
About Dr. Robert Soiffer, MD
Dr. Robert Soiffer, MD is a Medical Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780653261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Soiffer, MD has received a total of $156,635 in payments from pharmaceutical and medical device companies, with $16,138 received in 2024. These payments were reported across 119 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($138,130).
As a Medicare-enrolled provider, Soiffer has provided services to 953 Medicare beneficiaries, totaling 2,070 services with total Medicare billing of $174,912. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Boston, MA
- Active Since 03/16/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1780653261
Products in Payments
- PREVYMIS (Drug) $13,999
- DEFITELIO (Drug) $9,920
- JCAR017 (Drug) $7,500
- Leukine (Drug) $6,875
- Xospata (Drug) $6,820
- Venclexta (Drug) $5,764
- GLASSIA (Biological) $1,600
- MOZOBIL (Drug) $450.00
- RYLAZE (Drug) $143.43
- JAKAFI (Drug) $109.89
- Blincyto (Biological) $19.63
- Idhifa (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Boston
Dr. George Demetri, Md, MD
Medical Oncology — Payments: $1.6M
Medical Oncology $1.6M
Pasi Antero Janne, Md Phd, MD PHD
Medical Oncology — Payments: $1.1M
Medical Oncology $1.1M
Dr. Praful Ravi, Mb Bchir, MB BCHIR
Medical Oncology — Payments: $921,658
Medical Oncology $921,658
Dr. Alicia Morgans, Md, MD
Medical Oncology — Payments: $755,277
Medical Oncology $755,277
Dr. Erica Mayer, Md Mph, MD MPH
Medical Oncology — Payments: $665,160
Medical Oncology $665,160
Dr. Joaquin Bellmunt Molins, M.d, M.D
Medical Oncology — Payments: $610,701
Medical Oncology $610,701